| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 30/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product Name | Metformin HCl |
| Appearance | White Powder |
| CAS NO. | 1115-70-4 |
| Storage | Keep in a cool, dry, dark location |
Metformin HCl, also known as 1,1-Dimethylbiguanide HCl, is a pharmaceutical compound belonging to the biguanide class of drugs. It is primarily used as an oral hypoglycemic agent for the management of type 2 diabetes mellitus. With a molecular formula of C4H11N5·HCl and a molecular weight of approximately 165.63, Metformin HCl is a white to off-white crystalline powder that is soluble in water.
Diabetes Management: Metformin HCl is prescribed for patients with type 2 diabetes who do not achieve adequate glycemic control with diet and exercise alone. It is often the first-line pharmacological therapy for this condition.
Combination Therapy: It can be used in combination with other oral antidiabetic agents to enhance glycemic control in patients requiring more intensive therapy.
Other Indications: Besides diabetes, research is ongoing to explore the potential use of Metformin HCl in other areas such as cancer prevention, polycystic ovary syndrome, and aging-related conditions, although these applications are not yet approved for clinical use.
Blood Glucose Lowering: Metformin HCl acts primarily by reducing hepatic glucose production (inhibiting gluconeogenesis) and improving peripheral sensitivity, thereby lowering both fasting and postprandial blood glucose levels.
Weight Loss and Metabolic Benefits: It may also contribute to modest weight loss and has favorable effects on cardiovascular risk factors, such as reducing blood pressure and improving lipid profiles.
Anti-aging and Other Effects: Preliminary research suggests that Metformin HCl may have anti-aging properties and potential benefits in other non-diabetes-related conditions, but these findings require further clinical validation.
){kind=link}